Cel Sci CORP (CVM) — 10-K Filings
All 10-K filings from Cel Sci CORP. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
CEL-SCI Pushes Multikine to Confirmatory Study After Strong Phase III Data
— Dec 29, 2025 Risk: high
CEL-SCI Corporation, a late clinical-stage biotechnology company, reported no revenue for the fiscal year ended September 30, 2025, as its lead product candidat -
CEL SCI CORP Files 2024 10-K
— Jan 13, 2025 Risk: medium
CEL SCI CORP filed its 2024 10-K on January 13, 2025, reporting on its fiscal year ending September 30, 2024. The company, previously known as INTERLEUKIN 2 INC
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX